Types of Cancer We Treat

Myelodysplastic Syndromes

Our specialists provide expert care for people with myelodysplastic syndromes (MDS). These are conditions in which the blood-forming cells in the bone marrow are damaged, leading to a decreased number of red blood cells, white blood cells, or platelets. We use sophisticated testing to identify the type of MDS and determine the risk of the condition progressing. Then, we create a personalized and evidence-based treatment plan to meet your needs, ranging from watchful monitoring to stem cell transplantation.

Find a Doctor & Schedule
Diagnosis
Watchful Waiting
Medication
Blood Transfusions
Stem Cell Transplantation

Related News

High-Dose Vitamin C May Counter Leukemia
Read Story
Study Shows Potential for Vitamin C as Anti-Cancer Treatment
Read Story
Study Finds New Way to Target Stem Cell-Driven Blood Cancers
Read Story

Clinical Trials and Research Studies

Phase 5

An open-label Phase I study to assess the safety of NKR-2 treatment administration after a non-myeloablative preconditioning chemotherapy in relapse/refractory acute myeloid leukemia or myelodysplastic syndrome patients

Learn More

Phase 1

A Phase 1a/1b Dose Escalation and Expansion Trial of TTI-621 a Novel Biologic Targeting CD47 in Subjects with Relapsed or Refractory Hematologic Malignancies and Selected Solid Tumors

Learn More
View All Related Clinical Trials (2)